ARTERRA BIOSCIENCE
Research ARTERRA BIOSCIENCE (ARBS.MI) on Bullrun: market cap EUR 20.78M, P/E 10.3, dividend yield 4.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerARBS.MI
- ExchangeEXGM
- CountryItaly
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 20.78M
- P/E10.3
- Dividend yield4.9%
- Financial periodFY2025
- RevenueEUR 4.70M
- Revenue growth12.7%
- Net incomeEUR 2.01M
- Free cash flowEUR 1.54M
- Gross margin92.7%
Valuation Snapshot
latest market cap is EUR 20.78M; P/E is 10.3; dividend yield is 4.9%.
Peer valuation comparison
Latest P/E is 10.29x versus a Healthcare sector median of 24.46x (57.9% below).
Latest dividend yield is 4.87% versus a Healthcare sector median of 2.11% (130.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 4.70M | EUR 2.01M | EUR 1.54M | 92.7% | n/a | EUR 1.34M | EUR 260.35K | EUR 12.58M |
| FY2024 | EUR 4.17M | EUR 1.34M | EUR 399.41K | 87.5% | n/a | EUR 3.34M | EUR 356.43K | EUR 11.42M |
| FY2023 | EUR 3.34M | EUR 1.08M | EUR 943.17K | 91.8% | 0.17 | EUR 3.69M | EUR 386.08K | EUR 10.75M |
| FY2022 | EUR 3.59M | EUR 1.41M | EUR 1.30M | 97.5% | 0.21 | EUR 4.39M | EUR 489.31K | EUR 10.47M |
| FY2021 | n/a | n/a | n/a | n/a | 0.17 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-15 | EUR 20.78M | 10.3 | 4.7% | 0.15 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.15 EUR, yield 4.9%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.13 EUR |
| FY2024 | 0.1 EUR |
| FY2023 | 0.1 EUR |
| FY2022 | 0.05 EUR |
About ARTERRA BIOSCIENCE
Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. The company provides extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceuticals sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Naples, Italy.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ARTERRA BIOSCIENCE's market cap?
ARTERRA BIOSCIENCE's market capitalization is EUR 20.78M.
What is ARTERRA BIOSCIENCE's P/E ratio?
ARTERRA BIOSCIENCE's price-to-earnings (P/E) ratio is 10.3.
Does ARTERRA BIOSCIENCE pay a dividend?
ARTERRA BIOSCIENCE has a dividend yield of 4.9%.
What does ARTERRA BIOSCIENCE do?
Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. The company provides extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceuticals sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Naples, Italy.